| ID | 63540 |
| Title Alternative | 治療歴のないALK、ROS1、またはEGFR陽性非小細胞肺癌の前臨床モデルにおいてSHP2阻害はチロシンキナーゼ阻害剤の効果を増強する
|
| FullText URL | |
| Author |
Kano, Hirohisa
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
|
| Note | 岡山大学審査学位論文
Hirohisa Kano, Eiki Ichihara, Hiromi Watanabe, Kazuya Nishii, Chihiro Ando, Takamasa Nakasuka, Kiichiro Ninomiya, Yuka Kato, Toshio Kubo, Kammei Rai, Kadoaki Ohashi, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura; SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1-, or EGFR-altered Non–small Cell Lung Cancer. Mol Cancer Ther 1 September 2021; 20 (9): 1653–1662. https://doi.org/10.1158/1535-7163.MCT-20-0965
|
| Published Date | 2022-03-25
|
| Content Type |
Thesis or Dissertation
|
| Grant Number | 甲第6533号
|
| Granted Date | 2022-03-25
|
| Thesis Type |
Doctor of Philosophy in Medical Science
|
| Grantor | 岡山大学
|
| Thesis FullText |
Thesis or Dissertation (See FullText URL)
|
| Related Url | isVersionOf https://doi.org/10.1158/1535-7163.MCT-20-0965
|
| language |
English
|
| File Version | ETD
|
| Grant ID | 15301甲第6533号
|
| PubMed ID | |
| Copyright Holders | © 2021 American Association for Cancer Research
|
| DOI |
